Runchu Zhao

CAS Key Laboratory Of Pathogen Microbiology And Immunology
Beijing, 100101, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Bruton's tyrosine kinase inhibitor BTKi-2 inhibits mpox virus and vaccinia virus infection.

Bruton's tyrosine kinase inhibitor BTKi-2 inhibits mpox virus and vaccinia virus infection.

Journal: Virologica Sinica

Published: December 10, 2025

Anti-M1R/B6R antibody characterization and bispecific design for enhanced orthopoxvirus protection.

Anti-M1R/B6R antibody characterization and bispecific design for enhanced orthopoxvirus protection.

Journal: EMBO molecular medicine

Published: May 06, 2025

Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.

Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.

Journal: Journal of virology

Published: April 09, 2024

Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.

Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 18, 2023

Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections.

Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections.

Journal: Nature communications

Published: October 30, 2023

Cross-species recognition of bat coronavirus RsYN04 and cross-reaction of SARS-CoV-2 antibodies against the virus.

Cross-species recognition of bat coronavirus RsYN04 and cross-reaction of SARS-CoV-2 antibodies against the virus.

Journal: Zoological research

Published: October 07, 2023

VH-CH1 switch region-inserting multispecific antibody designs and their efficacy against SARS-CoV-2 in vitro and in vivo.

VH-CH1 switch region-inserting multispecific antibody designs and their efficacy against SARS-CoV-2 in vitro and in vivo.

Journal: Cell discovery

Published: August 06, 2023

Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animals.

Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animals.

Journal: National science review

Published: April 17, 2022

Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3.

Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3.

Journal: Immunity

Published: April 03, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026